Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6136912
[patent_doc_number] => 20110009439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/710909
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59982
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12710909
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710909 | Indene derivatives as pharmaceutical agents | Feb 22, 2010 | Issued |
Array
(
[id] => 8713301
[patent_doc_number] => 08399441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 12/708803
[patent_app_country] => US
[patent_app_date] => 2010-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 47
[patent_no_of_words] => 23739
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12708803
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/708803 | Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis | Feb 18, 2010 | Issued |
Array
(
[id] => 6403228
[patent_doc_number] => 20100179344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => '2-Alkylidene-18,19-Dinor-Vitamin D Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/709181
[patent_app_country] => US
[patent_app_date] => 2010-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12055
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20100179344.pdf
[firstpage_image] =>[orig_patent_app_number] => 12709181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/709181 | 2-Alkylidene-18,19-Dinor-Vitamin D Compounds | Feb 18, 2010 | Abandoned |
Array
(
[id] => 7651869
[patent_doc_number] => 20110301138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => ' PROCESS TO MAKE FUSIDIC ACID CREAM'
[patent_app_type] => utility
[patent_app_number] => 13/201627
[patent_app_country] => US
[patent_app_date] => 2010-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6153
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301138.pdf
[firstpage_image] =>[orig_patent_app_number] => 13201627
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201627 | Process to make fusidic acid cream | Feb 15, 2010 | Issued |
Array
(
[id] => 9620921
[patent_doc_number] => 08791095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-29
[patent_title] => 'Steroidal CYP17 inhibitors/antiandrogens'
[patent_app_type] => utility
[patent_app_number] => 13/145997
[patent_app_country] => US
[patent_app_date] => 2010-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8509
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145997
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145997 | Steroidal CYP17 inhibitors/antiandrogens | Feb 4, 2010 | Issued |
Array
(
[id] => 7663647
[patent_doc_number] => 20110312916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'NOVEL PRODRUGS OF STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS'
[patent_app_type] => utility
[patent_app_number] => 13/146004
[patent_app_country] => US
[patent_app_date] => 2010-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9700
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312916.pdf
[firstpage_image] =>[orig_patent_app_number] => 13146004
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146004 | NOVEL PRODRUGS OF STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS | Feb 4, 2010 | Abandoned |
Array
(
[id] => 8253096
[patent_doc_number] => 20120157419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/147071
[patent_app_country] => US
[patent_app_date] => 2010-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11842
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157419.pdf
[firstpage_image] =>[orig_patent_app_number] => 13147071
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/147071 | METHODS AND COMPOSITIONS FOR TREATING ALZHEIMER'S DISEASE | Jan 31, 2010 | Abandoned |
Array
(
[id] => 7728046
[patent_doc_number] => 20120012822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'AROMATIC COMPOUND AND METHOD FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/145487
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14925
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20120012822.pdf
[firstpage_image] =>[orig_patent_app_number] => 13145487
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145487 | AROMATIC COMPOUND AND METHOD FOR PRODUCING SAME | Jan 21, 2010 | Abandoned |
Array
(
[id] => 6576973
[patent_doc_number] => 20100273818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'INHIBITORS OF HEDGEHOG SIGNALING PATHWAYS, COMPOSITIONS AND USES RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 12/652134
[patent_app_country] => US
[patent_app_date] => 2010-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 39113
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273818.pdf
[firstpage_image] =>[orig_patent_app_number] => 12652134
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/652134 | INHIBITORS OF HEDGEHOG SIGNALING PATHWAYS, COMPOSITIONS AND USES RELATED THERETO | Jan 4, 2010 | Abandoned |
Array
(
[id] => 6320625
[patent_doc_number] => 20100113408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => '21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/641172
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22793
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113408.pdf
[firstpage_image] =>[orig_patent_app_number] => 12641172
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/641172 | 21-substituted progesterone derivatives as new antiprogestational agents | Dec 16, 2009 | Issued |
Array
(
[id] => 8496689
[patent_doc_number] => 20120296097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'PREPARATION METHOD OF ORIGINAL DYE OF VAT BROWN R'
[patent_app_type] => utility
[patent_app_number] => 13/516775
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6812
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516775
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/516775 | PREPARATION METHOD OF ORIGINAL DYE OF VAT BROWN R | Dec 16, 2009 | Abandoned |
Array
(
[id] => 6637640
[patent_doc_number] => 20100173883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => '7-HYDROXYEPIANDROSTERONE HAVING NEUROPROTECTIVE ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/639708
[patent_app_country] => US
[patent_app_date] => 2009-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4016
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173883.pdf
[firstpage_image] =>[orig_patent_app_number] => 12639708
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/639708 | 7-HYDROXYEPIANDROSTERONE HAVING NEUROPROTECTIVE ACTIVITY | Dec 15, 2009 | Abandoned |
Array
(
[id] => 6493416
[patent_doc_number] => 20100093687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Method Of Treating Disorder Related To High Cholesterol Concentration'
[patent_app_type] => utility
[patent_app_number] => 12/637165
[patent_app_country] => US
[patent_app_date] => 2009-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12142
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093687.pdf
[firstpage_image] =>[orig_patent_app_number] => 12637165
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/637165 | Method Of Treating Disorder Related To High Cholesterol Concentration | Dec 13, 2009 | Abandoned |
Array
(
[id] => 7774280
[patent_doc_number] => 08119622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => '7-phenyl-substituted tetracycline compounds'
[patent_app_type] => utility
[patent_app_number] => 12/635423
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9989
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119622.pdf
[firstpage_image] =>[orig_patent_app_number] => 12635423
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/635423 | 7-phenyl-substituted tetracycline compounds | Dec 9, 2009 | Issued |
Array
(
[id] => 6444947
[patent_doc_number] => 20100144688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => '23-Substituted Derivatives of Lupane-type Pentacyclic Triterpenoids'
[patent_app_type] => utility
[patent_app_number] => 12/634305
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22726
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144688.pdf
[firstpage_image] =>[orig_patent_app_number] => 12634305
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/634305 | 23-Substituted Derivatives of Lupane-type Pentacyclic Triterpenoids | Dec 8, 2009 | Abandoned |
Array
(
[id] => 6549229
[patent_doc_number] => 20100222425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'COMPOSITIONS AND TREATMENT METHODS-2'
[patent_app_type] => utility
[patent_app_number] => 12/633721
[patent_app_country] => US
[patent_app_date] => 2009-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 216892
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222425.pdf
[firstpage_image] =>[orig_patent_app_number] => 12633721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/633721 | 15-OXA-steroid compounds | Dec 7, 2009 | Issued |
Array
(
[id] => 6327275
[patent_doc_number] => 20100197647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'COMPOUNDS THAT INHIBIT OESTRONE SULPHATASE; COMPOSITIONS THEREOF; AND METHODS EMPLOYING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/628696
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17491
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197647.pdf
[firstpage_image] =>[orig_patent_app_number] => 12628696
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/628696 | COMPOUNDS THAT INHIBIT OESTRONE SULPHATASE; COMPOSITIONS THEREOF; AND METHODS EMPLOYING THE SAME | Nov 30, 2009 | Abandoned |
Array
(
[id] => 13763471
[patent_doc_number] => 10174070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => 6-substituted estradiol derivatives and methods of use
[patent_app_type] => utility
[patent_app_number] => 12/627874
[patent_app_country] => US
[patent_app_date] => 2009-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17521
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12627874
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/627874 | 6-substituted estradiol derivatives and methods of use | Nov 29, 2009 | Issued |
Array
(
[id] => 9311836
[patent_doc_number] => 08653054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => '2-(N-substituted piperazinyl) steroid derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/130621
[patent_app_country] => US
[patent_app_date] => 2009-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28738
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13130621
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/130621 | 2-(N-substituted piperazinyl) steroid derivatives | Nov 24, 2009 | Issued |
Array
(
[id] => 8294456
[patent_doc_number] => 08222237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-17
[patent_title] => 'Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones'
[patent_app_type] => utility
[patent_app_number] => 12/626398
[patent_app_country] => US
[patent_app_date] => 2009-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6178
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12626398
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/626398 | Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones | Nov 24, 2009 | Issued |